These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8053716)

  • 1. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
    Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
    Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study.
    Marghoob AA; Slade J; Kopf AW; Salopek TG; Rigel DS; Bart RS
    Br J Dermatol; 1996 Nov; 135(5):704-11. PubMed ID: 8977668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma risk in individuals with clinically atypical nevi.
    Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased incidence of multiple melanoma in sporadic and familial dysplastic nevus cell syndrome].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Sep; 40(9):548-52. PubMed ID: 2807914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five cases of coexistent primary ocular and cutaneous melanoma.
    Bataille V; Pinney E; Hungerford JL; Cuzick J; Bishop DT; Newton JA
    Arch Dermatol; 1993 Feb; 129(2):198-201. PubMed ID: 8434978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.
    Tiersten AD; Grin CM; Kopf AW; Gottlieb GJ; Bart RS; Rigel DS; Friedman RJ; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Jan; 17(1):44-8. PubMed ID: 1991880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
    Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
    J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors.
    Haenssle HA; Korpas B; Hansen-Hagge C; Buhl T; Kaune KM; Johnsen S; Rosenberger A; Schön MP; Emmert S
    Arch Dermatol; 2010 Mar; 146(3):257-64. PubMed ID: 20231495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
    Richtig E; Langmann G; Müllner K; Smolle J
    Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple primary melanoma revisited.
    Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
    Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
    Schenk M; Severson RK; Pawlish KS
    Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review.
    Slade J; Salopek TG; Marghoob AA; Kopf AW; Rigel DS
    Recent Results Cancer Res; 1995; 139():87-104. PubMed ID: 7597314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nevus and malignant cutaneous melanoma].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
    Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.